Search

everythinglearnresearchcommunity

for

Search:↓

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

The combination of encorafenib and binimetinib caused few skin issues.

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Vinblastine can help treat childhood ITP but may cause reversible side effects.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ayurvedic remedies may boost immunity and balance in cancer treatment but need more research.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Shaving and applying erythromycin cream and clotrimazole powder effectively treated trichomycosis axillaris.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Pexidartinib often causes liver issues and fatigue, especially in women.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Letrozole reduces seizures but not brain damage in mice.

Cyproterone helps women with hair loss caused by genetics. More research is needed to confirm the best dose.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.